Global Information
회사소개 | 문의 | 위시리스트

세계의 microRNA(miRNA) 시퀀싱 및 어세이 시장 예측(-2024년) : 라이브러리 준비, 소모품

miRNA Sequencing and Assay Market by Product (Library Preparation, Consumables), Technology (Sequencing By Synthesis, Nanopore, Ion Semiconductor Sequencing), End User (Research Institute, Academia, CRO), Region - Global Forecast To 2024

리서치사 MarketsandMarkets
발행일 2019년 03월 상품 코드 801099
페이지 정보 영문 99 Pages
가격
US $ 5,650 ₩ 6,691,000 PDF by E-mail (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 6,650 ₩ 7,875,000 PDF by E-mail (5-user License) help
동일 사업장 내 5명까지 공유하여 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 8,150 ₩ 9,652,000 PDF by E-mail (Corporate License) help
기업 내 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없지만, 동일 국가의 동일 사업장에 한정되며 해외지점 등은 포함되지 않습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 10,000 ₩ 11,843,000 PDF by E-mail (Global License) help
동일 기업의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없습니다. 100% 자회사는 동일 기업으로 간주됩니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


세계의 microRNA(miRNA) 시퀀싱 및 어세이 시장 예측(-2024년) : 라이브러리 준비, 소모품 miRNA Sequencing and Assay Market by Product (Library Preparation, Consumables), Technology (Sequencing By Synthesis, Nanopore, Ion Semiconductor Sequencing), End User (Research Institute, Academia, CRO), Region - Global Forecast To 2024
발행일 : 2019년 03월 페이지 정보 : 영문 99 Pages

세계의 microRNA(miRNA) 시퀀싱 및 어세이 시장은 2018년 1억 8,200만 달러에서 2024년까지 3억 4,300만 달러로 확대될 것으로 예측됩니다. 시장은 2018-2024년 연평균 성장률(CAGR)로 11.2%의 성장이 전망됩니다.

세계의 microRNA(miRNA) 시퀀싱 및 어세이 시장에 대해 조사 분석했으며, 시장 개요, 산업 동향, 부문별 시장 분석, 경쟁 상황, 주요 기업 등에 대한 체계적인 정보를 제공합니다.

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 주요 조사 결과

  • miRNA 시퀀싱 및 어세이 시장 개요
  • miRNA 시퀀싱 및 어세이 시장 : 기술별
  • 북미 - miRNA 시퀀싱 및 어세이 시장 : 제품별

제5장 시장 개요

  • 서론
  • 시장 역학
    • 성장 촉진요인
    • 기회
    • 과제

제6장 세계의 miRNA 시퀀싱 및 어세이 시장 : 제품별

  • 서론
  • 시퀀싱 소모품
  • 라이브러리 준비 키트

제7장 세계의 miRNA 시퀀싱 및 어세이 시장 : 기술별

  • 서론
  • 합성에 의한 시퀀싱
  • 이온 반도체 시퀀싱
  • 라이게이션에 의한 시퀀싱
  • 나노포어 시퀀싱

제8장 세계의 miRNA 시퀀싱 및 어세이 시장 : 최종사용자별

  • 서론
  • 연구 및 학술기관
  • 임상시험수탁기관(CRO)

제9장 세계의 miRNA 시퀀싱 및 어세이 시장 : 지역별

  • 서론
  • 북미
  • 유럽
  • 아시아태평양
  • 기타

제10장 경쟁 상황

  • 개요
  • 벤더 벤치마킹
  • 경쟁 리더십 매핑
  • 시장 순위 분석
  • 경쟁 상황과 동향

제11장 기업 개요

  • ILLUMINA, INC.
  • THERMO FISHER SCIENTIFIC
  • QIAGEN
  • PERKINELMER, INC.
  • TAKARA BIO, INC.
  • EW ENGLAND BIOLABS, INC.
  • NORGEN BIOTEK CORPORATION
  • RILINK BIOTECHNOLOGIES
  • EXOGEN
  • OXFORD NANOPORE TECHNOLOGIES

제12장 부록

KSM 19.03.13

LIST OF TABLES

  • TABLE 1: MIRNA SEQUENCING AND ASSAYS MARKET, BY PRODUCT 2016-2024 (USD MILLION)
  • TABLE 2: MIRNA SEQUENCING CONSUMABLES MARKET, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 3: NORTH AMERICA: MIRNA SEQUENCING CONSUMABLES MARKET, BY COUNTRY, 2016-2024 (USD MILLION)
  • TABLE 4: EUROPE: MIRNA SEQUENCING CONSUMABLES MARKET, BY COUNTRY, 2016-2024 (USD MILLION)
  • TABLE 5: MIRNA LIBRARY PREPARATION KITS MARKET, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 6: NORTH AMERICA: MIRNA LIBRARY PREPARATION KITS MARKET, BY COUNTRY, 2016-2024 (USD MILLION)
  • TABLE 7: EUROPE: MIRNA LIBRARY PREPARATION KITS MARKET, BY COUNTRY, 2016-2024 (USD MILLION)
  • TABLE 8: MIRNA SEQUENCING AND ASSAYS MARKET, BY TECHNOLOGY, 2016-2024 (USD MILLION)
  • TABLE 9: MIRNA SEQUENCING AND ASSAYS MARKET FOR SEQUENCING BY SYNTHESIS, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 10: NORTH AMERICA: MIRNA SEQUENCING AND ASSAYS MARKET FOR SEQUENCING BY SYNTHESIS, BY COUNTRY, 2016-2024 (USD MILLION)
  • TABLE 11: EUROPE: MIRNA SEQUENCING AND ASSAYS MARKET FOR SEQUENCING BY SYNTHESIS, BY COUNTRY, 2016-2024 (USD MILLION)
  • TABLE 12: MIRNA SEQUENCING AND ASSAYS MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 13: NORTH AMERICA: MIRNA SEQUENCING AND ASSAYS MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY COUNTRY, 2016-2024 (USD MILLION)
  • TABLE 14: EUROPE: MIRNA SEQUENCING AND ASSAYS MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY COUNTRY, 2016-2024 (USD MILLION)
  • TABLE 15: MIRNA SEQUENCING AND ASSAYS MARKET FOR SOLID SEQUENCING, BY REGION, 2016-2024 (USD THOUSAND)
  • TABLE 16: NORTH AMERICA: MIRNA SEQUENCING AND ASSAYS MARKET FOR SOLID SEQUENCING, BY COUNTRY, 2016-2024 (USD MILLION)
  • TABLE 17: EUROPE: MIRNA SEQUENCING AND ASSAYS MARKET FOR SOLID SEQUENCING, BY COUNTRY, 2016-2024 (USD MILLION)
  • TABLE 18: MIRNA SEQUENCING AND ASSAYS MARKET FOR NANOPORE SEQUENCING, BY REGION, 2016-2024 (USD THOUSAND)
  • TABLE 19: NORTH AMERICA: MIRNA SEQUENCING AND ASSAYS MARKET FOR NANOPORE SEQUENCING, BY COUNTRY, 2016-2024 (USD THOUSAND)
  • TABLE 20: EUROPE: MIRNA SEQUENCING AND ASSAYS MARKET FOR NANOPORE SEQUENCING, BY COUNTRY, 2016-2024 (USD THOUSAND)
  • TABLE 21: MIRNA SEQUENCING AND ASSAYS MARKET, BY END USER, 2016-2024 (USD MILLION)
  • TABLE 22: MIRNA SEQUENCING AND ASSAYS MARKET FOR RESEARCH AND ACADEMIC INSTITUTES, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 23: NORTH AMERICA: MIRNA SEQUENCING AND ASSAYS MARKET FOR RESEARCH AND ACADEMIC INSTITUTES, BY COUNTRY, 2016-2024 (USD MILLION)
  • TABLE 24: EUROPE: MIRNA SEQUENCING AND ASSAYS MARKET FOR RESEARCH AND ACADEMIC INSTITUTES, BY COUNTRY, 2016-2024 (USD MILLION)
  • TABLE 25: MIRNA SEQUENCING AND ASSAYS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 26: NORTH AMERICA: MIRNA SEQUENCING AND ASSAYS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2016-2024 (USD MILLION)
  • TABLE 27: EUROPE: MIRNA SEQUENCING AND ASSAYS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2016-2024 (USD MILLION)
  • TABLE 28: MIRNA SEQUENCING AND ASSAYS MARKET, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 29: MIRNA SEQUENCING AND ASSAYS MARKET, BY COUNTRY, 2016-2024 (USD MILLION)
  • TABLE 30: NORTH AMERICA: MIRNA SEQUENCING AND ASSAYS MARKET, BY COUNTRY, 2016-2024 (USD MILLION)
  • TABLE 31: NORTH AMERICA: MIRNA SEQUENCING AND ASSAYS MARKET, BY PRODUCT, 2016-2024 (USD MILLION)
  • TABLE 32: NORTH AMERICA: MIRNA SEQUENCING AND ASSAYS MARKET, BY TECHNOLOGY, 2016-2024 (USD MILLION)
  • TABLE 33: NORTH AMERICA: MIRNA SEQUENCING AND ASSAYS MARKET, BY END USER, 2016-2024 (USD MILLION)
  • TABLE 34: US: MIRNA SEQUENCING AND ASSAYS MARKET, BY PRODUCT, 2016-2024 (USD MILLION)
  • TABLE 35: US: MIRNA SEQUENCING AND ASSAYS MARKET, BY TECHNOLOGY, 2016-2024 (USD MILLION)
  • TABLE 36: US: MIRNA SEQUENCING AND ASSAYS MARKET, BY END USER, 2016-2024 (USD MILLION)
  • TABLE 37: CANADA: MIRNA SEQUENCING AND ASSAYS MARKET, BY PRODUCT, 2016-2024 (USD MILLION)
  • TABLE 38: CANADA: MIRNA SEQUENCING AND ASSAYS MARKET, BY TECHNOLOGY, 2016-2024 (USD THOUSAND)
  • TABLE 39: CANADA: MIRNA SEQUENCING AND ASSAYS MARKET, BY END USER, 2016-2024 (USD MILLION)
  • TABLE 40: EUROPE: MIRNA SEQUENCING AND ASSAYS MARKET, BY COUNTRY, 2016-2024 (USD MILLION)
  • TABLE 41: EUROPE: MIRNA SEQUENCING AND ASSAYS MARKET, BY PRODUCT, 2016-2024 (USD MILLION)
  • TABLE 42: EUROPE: MIRNA SEQUENCING AND ASSAYS MARKET, BY TECHNOLOGY, 2016-2024 (USD MILLION)
  • TABLE 43: EUROPE: MIRNA SEQUENCING AND ASSAYS MARKET, BY END USER, 2016-2024 (USD MILLION)
  • TABLE 44: GERMANY: MIRNA SEQUENCING AND ASSAYS MARKET, BY PRODUCT, 2016-2024 (USD MILLION)
  • TABLE 45: GERMANY: MIRNA SEQUENCING AND ASSAYS MARKET, BY TECHNOLOGY, 2016-2024 (USD MILLION)
  • TABLE 46: GERMANY: MIRNA SEQUENCING AND ASSAYS MARKET, BY END USER, 2016-2024 (USD MILLION)
  • TABLE 47: UK: MIRNA SEQUENCING AND ASSAYS MARKET, BY PRODUCT, 2016-2024 (USD MILLION)
  • TABLE 48: UK: MIRNA SEQUENCING AND ASSAYS MARKET, BY TECHNOLOGY, 2016-2024 (USD MILLION)
  • TABLE 49: UK: MIRNA SEQUENCING AND ASSAYS MARKET, BY END USER, 2016-2024 (USD MILLION)
  • TABLE 50: ROE: MIRNA SEQUENCING AND ASSAYS MARKET, BY PRODUCT, 2016-2024 (USD MILLION)
  • TABLE 51: ROE: MIRNA SEQUENCING AND ASSAYS MARKET, BY TECHNOLOGY, 2016-2024 (USD MILLION)
  • TABLE 52: ROE: MIRNA SEQUENCING AND ASSAYS MARKET, BY END USER, 2016-2024 (USD MILLION)
  • TABLE 53: APAC: MIRNA SEQUENCING AND ASSAYS MARKET, BY PRODUCT, 2016-2024 (USD MILLION)
  • TABLE 54: APAC: MIRNA SEQUENCING AND ASSAYS MARKET, BY TECHNOLOGY, 2016-2024 (USD MILLION)
  • TABLE 55: APAC: MIRNA SEQUENCING AND ASSAYS MARKET, BY END USER, 2016-2024 (USD MILLION)
  • TABLE 56: ROW: MIRNA SEQUENCING AND ASSAYS MARKET, BY PRODUCT, 2016-2024 (USD MILLION)
  • TABLE 57: ROW: MIRNA SEQUENCING AND ASSAYS MARKET, BY TECHNOLOGY, 2016-2024 (USD THOUSANDS)
  • TABLE 58: ROW: MIRNA SEQUENCING AND ASSAYS MARKET, BY END USER, 2016-2024 (USD MILLION)
  • TABLE 59: COLLABORATIONS, PARTNERSHIPS, AND AGREEMENTS, 2016-2018
  • TABLE 60: PRODUCT LAUNCHES, 2016-2018
  • TABLE 61: ACQUISITIONS, 2016-2018

LIST OF FIGURES

  • FIGURE 1: MIRNA SEQUENCING AND ASSAYS MARKET
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATIONS, AND REGION
  • FIGURE 4: BOTTOM-UP APPROACH
  • FIGURE 5: TOP-DOWN APPROACH
  • FIGURE 6: DATA TRIANGULATION METHODOLOGY
  • FIGURE 7: MIRNA SEQUENCING & ASSAYS MARKET, BY PRODUCT, 2018 VS. 2024 (USD MILLION)
  • FIGURE 8: MIRNA SEQUENCING & ASSAYS MARKET, BY TECHNOLOGY, 2018 VS. 2024 (USD MILLION)
  • FIGURE 9: MIRNA SEQUENCING & ASSAYS MARKET, BY END USER, 2018 VS. 2024 (USD MILLION)
  • FIGURE 10: GEOGRAPHICAL SNAPSHOT OF THE MIRNA SEQUENCING & ASSAYS MARKET
  • FIGURE 11: INCREASING RESEARCH ACTIVITIES IN THE LIFE SCIENCE INDUSTRY -A KEY DRIVER FOR MARKET GROWTH
  • FIGURE 12: SEQUENCING BY SYNTHESIS TO CONTINUE TO DOMINATE THE MIRNA SEQUENCING AND ASSAYS MARKET IN 2024
  • FIGURE 13: SEQUENCING CONSUMABLES ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN MIRNA SEQUENCING AND ASSAYS MARKET IN 2018
  • FIGURE 14: MIRNA SEQUENCING AND ASSAYS MARKET: DRIVERS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 15: COST PER GENOME, 2008-2017
  • FIGURE 16: NORTH AMERICA: MIRNA SEQUENCING AND ASSAYS MARKET SNAPSHOT
  • FIGURE 17: EUROPE: MIRNA SEQUENCING AND ASSAYS MARKET SNAPSHOT
  • FIGURE 18: MIRNA SEQUENCING AND ASSAYS MARKET (GLOBAL), COMPETITIVE LEADERSHIP MAPPING, 2017
  • FIGURE 19: RANK OF COMPANIES IN THE GLOBAL MIRNA SEQUENCING AND ASSAYS MARKET, 2017
  • FIGURE 20: ILLUMINA: COMPANY SNAPSHOT
  • FIGURE 21: THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT
  • FIGURE 22: QIAGEN N.V: COMPANY SNAPSHOT
  • FIGURE 23: PERKINELMER, INC.: COMPANY SNAPSHOT
  • FIGURE 24: TAKARA BIO, INC.: COMPANY SNAPSHOT

"The miRNA sequencing and assays market is expected to grow at a CAGR of 11.2% during the forecast period."

The miRNA sequencing and assays market is projected to reach USD 343 million by 2024 from USD 182 million in 2018, at a CAGR of 11.2%. The miRNA sequencing and assays market is driven by various factors such as the advantages of miRNA sequencing over other technologies, increasing research funding for genomics, and the decreasing cost of sequencing. However, the dearth of skilled professionals is expected to limit market growth to a certain extent.

"The sequencing consumables segment held the dominant share of the market in 2018."

Based on product, the miRNA sequencing & assays market is segmented into library preparation kits and sequencing consumables. Sequencing consumables dominated the market with a larger share in 2018. The large share of this segment can primarily be attributed to the repeat purchases of kits due to their high requirement and the high costs compared to library preparation kits.

"The sequencing by synthesis segment is projected to hold the largest market share of the market during the forecast period."

By technology, the miRNA sequencing & assays market is segmented into sequencing by synthesis, ion semiconductor sequencing, SOLiD, and Nanopore sequencing. The sequencing by synthesis segment dominated the market with the largest share in 2018 due to the technological advancements in sequencing by synthesis platforms and the reduced cost of sequencing.

"Asia Pacific is expected to record the highest growth rate during the forecast period."

The APAC miRNA sequencing and assays market, particularly in China, Japan, South Korea, Singapore, and India is expected to witness high growth in the next five years. The rising R&D funding for life sciences research, rapid growth of its life sciences industry, increasing adoption of NGS for miRNA analysis are the major factors driving the growth of this market.

Breakdown of Profiles of Primary Participants:

In-depth interviews were conducted with CEOs, marketing directors, other innovation and technology directors, and executives from various key organizations operating in the microscope software market.

  • By Company Type: Tier 1: 48%, Tier 2: 34%, and Tier 3: 18%
  • By Designation: C-level Executives: 42%, Directors: 14%, and Others: 18%
  • By Region: North America: 38%, Europe: 25%, APAC: 30%, and RoW: 7%

The miRNA sequencing and assays market report includes details of the major players in the miRNA sequencing & assays market such as Illumina (US), Thermo Fisher Scientific (US), QIAGEN (Germany), Takara Bio (Japan), and NEB (UK), among others. The study includes an in-depth competitive analysis of these key players in the miRNA sequencing and assays market, along with their company profiles, recent developments, and key market strategies.

Research Coverage:

The market study covers the miRNA sequencing and assays market across various segments. It aims at estimating the market size and the growth potential of this market across different segments on the basis of products, technologies, and end users. The study also includes an in-depth competitive analysis of the key players in the market; along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will provide market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall miRNA sequencing and assays market and its subsegments. This report will help the stakeholders to understand the competitive landscape, to gain insights to better position their businesses, and to plan suitable go-to-market strategies. The report will also help the stakeholders to understand the pulse of the market and will provide them with information on key market drivers, restraints, challenges, and opportunities.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. STAKEHOLDERS
  • 1.6. LIMITATIONS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH APPROACH
    • 2.1.1. SECONDARY RESEARCH
      • 2.1.1.1. Key data from secondary sources
    • 2.1.2. PRIMARY RESEARCH
      • 2.1.2.1. Key data from primary sources
      • 2.1.2.2. Break down of primaries
      • 2.1.2.3. Key industry insights
  • 2.2. MARKET SIZE ESTIMATION
  • 2.3. DATA TRIANGULATION APPROACH
  • 2.4. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. MIRNA SEQUENCING & ASSAYS MARKET OVERVIEW
  • 4.2. MIRNA SEQUENCING & ASSAYS MARKET, BY TECHNOLOGY (2016-2024)
  • 4.3. NORTH AMERICA: MIRNA SEQUENCING & ASSAYS MARKET, BY PRODUCT (2018)

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. MARKET DRIVERS
      • 5.2.1.1. Advantages of miRNA sequencing over other technologies
      • 5.2.1.2. Increasing research funding for genomics
      • 5.2.1.3. Decreasing cost of sequencing
    • 5.2.2. MARKET OPPORTUNITIES
      • 5.2.2.1. Increasing focus on miRNA biomarker discovery
    • 5.2.3. MARKET CHALLENGES
      • 5.2.3.1. Dearth of skilled professionals

6. MIRNA SEQUENCING AND ASSAYS MARKET, BY PRODUCT

  • 6.1. INTRODUCTION
  • 6.2. SEQUENCING CONSUMABLES
    • 6.2.1. INCREASING DEMAND FOR MIRNA SEQUENCING IS BOOSTING THE ADOPTION OF SEQUENCING CONSUMABLES
  • 6.3. LIBRARY PREPARATION KITS
    • 6.3.1. LIBRARY PREPARATION KITS SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD

7. MIRNA SEQUENCING AND ASSAYS MARKET, BY TECHNOLOGY

  • 7.1. INTRODUCTION
  • 7.2. SEQUENCING BY SYNTHESIS
    • 7.2.1. SEQUENCING BY SYNTHESIS SEGMENT ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2018
  • 7.3. ION SEMICONDUCTOR SEQUENCING
    • 7.3.1. PLATFORMS DEVELOPED USING THIS TECHNOLOGY ARE LOW-COST INSTRUMENTS AND POSSESS HIGH-THROUGHPUT CAPABILITIES
  • 7.4. SEQUENCING BY OLIGONUCLEOTIDE LIGATION AND DETECTION
    • 7.4.1. SOLID SEQUENCING OFFERS ACCURATE SEQUENCING OF SHORT READS
  • 7.5. NANOPORE SEQUENCING
    • 7.5.1. NANOPORE SEQUENCING SEGMENT TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD

8. MIRNA SEQUENCING AND ASSAYS MARKET, BY END USER

  • 8.1. INTRODUCTION
  • 8.2. RESEARCH AND ACADEMIC INSTITUTES
    • 8.2.1. RESEARCH AND ACADEMIC INSTITUTES SEGMENT TO DOMINATE THIS SEGMENT
  • 8.3. CONTRACT RESEARCH ORGANIZATIONS
    • 8.3.1. CONTRACT RESEARCH ORGANIZATIONS SUCH AS GENOMICS SERVICES COMPANIES TO GROW AT HIGHEST CAGR"

9. MIRNA SEQUENCING AND ASSAYS MARKET, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. NORTH AMERICA
    • 9.2.1. US
      • 9.2.1.1. US dominates the north american miRNA sequencing and assays market, due to the favorable funding scenario for research and strong presence of key market players
    • 9.2.2. CANADA
      • 9.2.2.1. Increase in genomics research to drive the adoption of mirna sequencing in Canada
  • 9.3. EUROPE
    • 9.3.1. GERMANY
      • 9.3.1.1. Growth of the genomics market to drive the growth of the market growth
    • 9.3.2. UK
      • 9.3.2.1. Government initiatives in genomics to drive the market for mirna sequencing
    • 9.3.3. ROE
  • 9.4. ASIA PACIFIC
  • 9.5. REST OF THE WORLD

10. COMPETITIVE LANDSCAPE

  • 10.1. OVERVIEW
  • 10.2. VENDOR BENCHMARKING
  • 10.3. COMPETITIVE LEADERSHIP MAPPING
    • 10.3.1. VISIONARY LEADERS
    • 10.3.2. INNOVATORS
    • 10.3.3. DYNAMIC DIFFERENTIATORS
    • 10.3.4. EMERGING COMPANIES
  • 10.4. MARKET RANKING ANALYSIS, 2017
  • 10.5. COMPETITIVE SITUATION AND TRENDS
    • 10.5.1. COLLABORATIONS, PARTNERSHIPS, AND AGREEMENTS
    • 10.5.2. PRODUCT LAUNCHES
    • 10.5.3. ACQUISITIONS

11. COMPANY PROFILES (Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*

  • 11.1. ILLUMINA, INC.
  • 11.2. THERMO FISHER SCIENTIFIC
  • 11.3. QIAGEN
  • 11.4. PERKINELMER, INC.
  • 11.5. TAKARA BIO, INC.
  • 11.6. NEW ENGLAND BIOLABS, INC.
  • 11.7. NORGEN BIOTEK CORPORATION
  • 11.8. TRILINK BIOTECHNOLOGIES
  • 11.9. LEXOGEN
  • 11.10. OXFORD NANOPORE TECHNOLOGIES

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

12. APPENDIX

  • 12.1. DISCUSSION GUIDE
  • 12.2. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3. AVAILABLE CUSTOMIZATIONS
  • 12.4. RELATED REPORTS
  • 12.5. AUTHOR DETAILS
Back to Top
전화 문의
F A Q